Myelin protein expression in lymphoid tissues: Implications for peripheral tolerance

Immunological Reviews

Volumn 164, Issue , 1998, Pages 81-92

  Voskuhl, Rhonda R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MYELIN BASIC PROTEIN; MYELIN PROTEIN; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HYPOTHESIS; IMMUNOLOGICAL TOLERANCE; LYMPH NODE; LYMPHOID TISSUE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CHRONIC DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNE TOLERANCE; LYMPHOID TISSUE; MICE; MODELS, IMMUNOLOGICAL; MYELIN BASIC PROTEINS; MYELIN PROTEINS; MYELIN PROTEOLIPID PROTEIN; RECURRENCE; T-LYMPHOCYTES;

EID: 0031756654     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01210.x     Document Type: Article

References (56)

1. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-187.
2. Lindsey JW, Pappolla M, Steinman L. Reinduction of experimental autoimmune encephalomyelitis in mice. Cell Immunol 1995;162:235-240.
3. Fallis RJ, Powers ML, Sy M, Weiner HL. Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis: analysis of basic protein-reactive cells in lymphoid organs and the nervous system of donor and recipient animals. J Neuroimmunol 1987;14:205-219.
4. Sakai K, Tabira T, Endoh M, Steinman L. Ia expression in chronic relapsing experimental allergic encephalomyelitis induced by long-term cultured T cell lines in mice. Lab Invest 1986;54:345-352.
5. Voskuhl RR, Farris RW, Nagasato K, McFarland HF, Dubois-Dalcq M. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein. J Neuroimmunol 1996;70:103-111.
6. Naparstek Y, et al. Effector T lymphocyte line cells migrate to the thymus and persist there. Nature 1982;300:262-264.
7. Naparstek Y, et al. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of cell lines. Eur J Immunol 1983;13:418-423.
8. Lehmann PV, Forsthurber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
9. Cross AH, Tuohy VK, Raine CS. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol 1993;146:261-269.
10. Yu M, Johnson JM, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med 1996;83:1777-1788.
11. McRae BL, Vanderlugt CL, Del Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85.
12. Smilek DE, Wraith DC, Hodgkinson S, Dwivedy S, Steinman L, McDevitt HO. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1991;88:9633-9637.
13. Su XM, Sriram S. Treatment of chronic relapsing experimental allergic encephalomyelitis with the intravenous administration of splenocytes coupled to encephalitogenic peptide 91-103 of myelin basic protein. J Neuroimmunol 1991;34:181-190.
14. Alliot F, Pessac B. Macrophages express glial markers. Biol Cell 1988;63:109-111.
15. Mathisen PM, Pease S, Garvey J, Hood L, Readhead C. Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. Proc Natl Acad Sci USA 1993;90:10125-10129.
16. Grima B, Zelenika D, Pessac B. A novel transcript overlapping the myelin basic protein gene. J Neurochem, 1992;59:2318-2323.
17. Campagnoni AT, et al. Structure and developmental regulation of golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells of the oligodendrocyte lineage in the brain. J Biol Chem 1993;268:4930-4938.
18. Zelenika D, Grima B, Pessac B. A new family of transcripts of the myelin basic protein gene: expression in the brain and immune system. J Neurochem 1993;60:1574-1577.
19. Pitchekian-Halabi H, Campagnoni C, Skinner E, Kampf K, Campagnoni AT, Voskuhl RR. Strain-related differences in the ability of T cells to recognize proteins encoded by the golli-myelin basic protein gene. J Neuroimmunol 1996;68:121-129.
20. Kitamura K, et al. Expression of a novel transcript of the myelin basic protein gene. J Neuroimmunol 1990;54:2032-2041.
21. Pribyl TM, et al. The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in immune and central nervous systems. Proc Natl Acad Sci USA 1993;90: 10695-10699.
22. Pribyl TM, et al. Expression of myelin proteolipid protein gene in the human fetal thymus. J Neuroimmunol 1996;67:125-130.
23. Pribyl TM, Campagnoni C, Kampf K, Handley VW, Campagnoni AT. The major myelin protein genes are expressed in the human thymus. J Neurosci Res 1996;45:812-819.
24. Grima B, Zelenika D, Javoy-Agid F, Pessac B. Identification of new human myelin basic protein transcripts in the immune and central nervous systems. Neurobiol Dis 1994;1:61-66.
25. Tranquill LR, et al. Human T lymphocytes specific for the immunodominant 83-99 epitope of myelin basic protein: recognition of golli-MBP HOG7. J Neurosci Res 1996;45:820-828.
26. Fritz RB, Kalvakolanu I. Thymic expression of the golli myelin basic protein in the SJL/J mouse. J Neuroimmunol 1995;57:93-99.
27. MacKenzie-Graham A, Pribyl TM, Kim S, Porter VR, Campagnoni AT, Voskuhl RR. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J Immunol 1997;159:4602-4610.
28. MacKenzie-Graham A, Kim S, Campagnoni AT, Voskuhl RR. MBP and PLP expression in lymph node, thymus and spleen: implications for peripheral tolerance (Submitted).
29. Kalwy S, Marty MC, Bausero P, Pessac B. Myelin basic protein-related proteins in mouse brain and immune tissues. J Neurochem 1998;70:435-438.
30. Fritz RB, Zhao ML. Thymic expression of myelin basic protein (MBP); activation of MBP-specific T cells by thymic cells in the absence of exogenous MBP. J Immunol 1996;157:5249-5253.
31. Miller SD, et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995;3:739-745.
32. Steinman L. The use of monoclonal antibodies for treatment of autoimmune disease. J Clin Immunol 1990;10:30S-38S.
33. Sharma SD, et al. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc Natl Acad Sci USA 1991;88:11465-11469.
34. Falcone M, Bloom BR. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med 1997;185:901-907.
35. Mustafa M, Vingsbo C, Olsson T, Issazadeh S, Ljungdahl A, Holmdahl R. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles. J Immunol 1994;153:3337-3344.
36. + cells in T cell receptor peptide-induced clonal unresponsiveness. Science 1993;259:91-94.
37. + cells mediate active suppression. J Immunol 1995;155:910-916.
38. H2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol 1991;146:1750-1758.
39. Johnson JG, Jenkins MK. The role of anergy in peripheral T cell unresponsiveness. Life Sci 1994;55:1767-1780.
40. Lenschow DJ, Bluestone JA. T cell co-stimulation and in vivo tolerance. Curr Opin Immunol 1993;5:747-752.
41. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM. The role of B7-1/B7-2: CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol Rev 1996;153:5-26.
42. + T cells differing in CD45R expression. J Immunol 1992;149:2300-2306.
43. Gerritse K, et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996;93:2499-2504.
44. Noelle RJ, Mackey M, Foy T, Buhlmann J, Burns C. CD40 and its ligand in autoimmunity. Ann N Y Acad Sci 1997;815:384-391.
45. Noelle RJ. CD40 and its ligand in host defense. Immunity 1996;4:415-419.
46. Powell MB, et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 1990;2:539-544.
47. H1 lymphokine subtype. Cell Immunol 1989;124:132-143.
48. Kuchroo VK, Martin CA, Greer JM, Ju ST, Sobel RA, Dorf ME. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993;151:4371-4382.
49. Florentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-2095.
50. Saoudi A, Simmonds S, Huitinga I, Mason D. Prevention of experimental autoimmune encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J Exp Med 1995;182:335-344.
51. Wolf SD, Dittel BN, Hardardottir F, Janeway CA. Experimental autoimmune encephalomyelitis induction in genetically B-cell deficient mice. J Exp Med 1996;184:2271-2278.
52. Wekerle H, Bradl M, Linington C, Kaab G, Kojima K. The shaping of the brain-specific T lymphocyte repertoire in the thymus. Immunol Rev 1996;149:231-243.
53. Touhy VK, Yu M, Weinstock-Guttman B, Kinkel RP. Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 1997;99:1682-1690.
54. Wucherpfennig KW, et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1997;152:5581-5592.
55. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994;179:973-984.
56. Lodge PA, Johnson C, Sriram S. Frequency of MBP and MBP peptide-reactive T cells in the HPRT mutant T-cell population of MS patients. Neurology 1996;46:1410-1415.